Find uplifting stories about heroes, innovations, and solutions
7091 results for "lymphoma treatment"
A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients. The treatment could prevent cancer recurrence in high-risk patients for the first time.
A 15-year study reveals that 42% of advanced follicular lymphoma patients can now be considered cured after standard treatment, challenging decades of medical belief that this cancer was incurable. Relapse rates dropped from nearly 7% in the first five years to just 0.6% after 15 years.
St. David's South Austin became the first hospital globally to enroll a patient in a groundbreaking lymphoma treatment trial. The new therapy targets cancer cells in ways previous treatments couldn't reach, offering hope to patients who've run out of options.
A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option. The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.
The FDA just approved Beqalzi, the first BCL2 inhibitor for patients with relapsed mantle cell lymphoma who've tried other treatments. Over half the patients in trials responded to the new therapy, offering fresh hope for those with limited options.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
Dogs with lymphoma finally have treatments designed just for them. Two new FDA-approved drugs are giving veterinarians powerful, proven tools to fight one of the most common cancers in dogs.
Robert Oman has been cancer-free for two decades thanks to a clinical trial that's rewriting what doctors thought possible about follicular lymphoma. New research shows 42% of patients may be functionally cured of a disease once considered incurable.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
More than 250 lymphoma survivors will learn stress management and coping techniques through a groundbreaking national trial. The free virtual program treats resilience as a teachable skill, not something you're born with.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A lymphoma survivor in Qatar is sharing his cancer journey to give hope to others facing similar battles. Mohamed Othman's story of faith and determination shows that recovery is possible even through the toughest challenges.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
Showing 20 of 7091